carteolol has been researched along with Corneal Diseases in 2 studies
Carteolol: A beta-adrenergic antagonist used as an anti-arrhythmia agent, an anti-angina agent, an antihypertensive agent, and an antiglaucoma agent.
Corneal Diseases: Diseases of the cornea.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chikama, T | 1 |
| Araie, M | 1 |
| Nishida, T | 1 |
| Tanito, M | 1 |
| Takanashi, T | 1 |
| Kaidzu, S | 1 |
| Yoshida, Y | 1 |
| Ohira, A | 1 |
1 trial available for carteolol and Corneal Diseases
| Article | Year |
|---|---|
[Influence on ocular surface and intraocular pressure of switching from preservative-containing to preservative-free carteolol hydrochloride ophthalmic solution].
Topics: Aged; Aged, 80 and over; Carteolol; Corneal Diseases; Female; Glaucoma; Humans; Intraocular Pressure | 2013 |
1 other study available for carteolol and Corneal Diseases
| Article | Year |
|---|---|
Cytoprotective effects of rebamipide and carteolol hydrochloride against ultraviolet B-induced corneal damage in mice.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Adrenergic beta-Antagonists; Alanine; Animals; Anti-Ulcer Agents; Carte | 2003 |